Cystic fibrosis (CF) is an inherited disease caused by
a change (mutation) in the cystic fibrosis transmembrane regulator (CFTR)
gene. It is a chronic, progressive disease that causes
mucus to become thick and sticky. The mucus builds up
and clogs passages in many of the body's organs, but primarily in the
lungs and the pancreas. In the lungs, the mucus can cause serious breathing
problems and lung disease. In the pancreas, the mucus can cause digestive
problems and malnutrition, which can lead to problems with growth and
development.
Cystic fibrosis is usually diagnosed during childhood. On average,
people who have cystic fibrosis live into their mid-to-late 30s, although new
treatments are making it possible for some people to live into their 40s and
longer.
What Causes Cystic Fibrosis?
Cystic fibrosis is a
genetic disorder. A child must inherit two defective
CF genes (one defective gene from each parent) to have the disease.
A person who has inherited only one defective CF gene is a
carrier of cystic fibrosis and does not have the
disease but can pass it on to his or her children. This person can also pass on
carrier status.
If only one parent is a carrier of a defective
CF gene, the child will not have CF. But there is a 50% (1-in-2) chance that
the child will be a CF carrier.
If both parents are carriers, there
is a 25% (1-in-4) chance that the child will have CF, but a 50% chance that the
child will be a carrier.
What Is Carrier Screening?
Cystic fibrosis carrier screening is a blood test that determines
whether you are a carrier of the defective gene that causes cystic fibrosis.
The test can help you determine whether you and your partner have an increased
chance of having a child born with CF.
Who Should Be Screened?
Genetic testing is available to screen people who want to determine
whether they may be carriers of CF. This type of genetic testing allows parents
to find out if they have an increased chance of having a child with CF. Anyone
who is interested in knowing his or her carrier status can request the test,
but the test can be ordered only by a health professional.
Genetic counseling to help you understand the meaning
and possible results of the test is recommended prior to genetic
testing.
Partners of people with CF. If one partner has CF and the other
partner has the defective CF gene, a child will have a 50% chance of having
CF.
Couples planning to have children.
Pregnant women
(and their partners) who seek prenatal care, regardless of family history.
What If I Am a Carrier?
If tests show that you are a carrier of CF, your partner should
also be tested. Both parents must be carriers of CF for a child to have the
disease. If tests show that your partner is not a carrier of the CF gene, there
is a very small chance that you will have a child with CF.
If you and your partner are both carriers of CF there is a 1-in-4
(25%) chance that your child will have CF.3
If you are not already pregnant, you may wish
to have genetic counseling to understand your risks and options if you decide
to have children.
The blood test can detect whether a person is a carrier of CF in
about 90 out of 100 CF carriers. This rate is not the same among all racial and
ethnic groups. There is a small risk that you may be a CF carrier even when the
test results are negative.4
Should I Be Screened?
The decision to have cystic fibrosis carrier screening is a
personal one. You may wish to be tested if you are concerned that you or your
partner might be carriers of CF. This may be more likely if either of you have
a family member with the disease. 3
Some people decide to be tested to help determine their risks if
they choose to have children. Among whites, about 1 in 29 is a carrier of a
defective CF gene. CF is much less common in other racial and ethnic
groups.4
Carrier testing is expensive. Another factor that may guide the
decision to have testing is whether the cost of testing is covered by your
insurance company.
You may decide to have carrier testing for CF if you are already
pregnant. The test results may influence your decision about your pregnancy or
help you make decisions about the care of your newborn child.
Why Not Be Screened?
There may be reasons you would choose not to have carrier
testing.
You think that your risk of being a carrier is
low. This may be true if you are an African American or an Asian American. The
incidence of CF is lower in these groups.
You are already pregnant
and the information obtained from testing will not affect your decision to
continue your pregnancy. Remember, though, that CF test results can provide
valuable information for the care of your unborn child.
Carrier
testing is expensive. You may decide not to have testing if your insurance does
not pay for it.
Testing does not identify all people who have a
mutation in the CF gene. There is a small chance that you are a carrier even if
the results are normal (negative).
Other Places To Get Help
Organizations
Cystic Fibrosis Foundation
6931 Arlington Road
Bethesda, MD 20814
Phone:
1-800-FIGHT CF (1-800-344-4823) (301) 951-4422
Fax:
(301) 951-6378
E-mail:
info@cff.org
Web Address:
www.cff.org
This organization coordinates, supports, and accredits cystic
fibrosis centers nationwide and provides funds and support for research.
Genetic Alliance
4301 Connecticut Avenue NW
Suite 404
Washington, DC 20008-2369
Phone:
1-800-336-GENE (1-800-336-4363) (202) 966-5557
Fax:
(202) 966-8553
E-mail:
info@geneticalliance.org
Web Address:
www.geneticalliance.org
The Genetic Alliance is an international organization
made up of millions of people with genetic conditions and more than 600
advocacy, research, and health care organizations that represent their
interests. The Alliance builds partnerships to promote healthy lives for all
those living with genetic conditions.
The Genetic Alliance
promotes healthy lives by working to speed the translation of genetic advances
into quality and affordable health care, public awareness, and
consumer-centered public policies.
Genetic Testing for Cystic Fibrosis. NIH Consensus Statement, vol. 15, no. 4 (1997 April
14-16).
American College of Obstetricians and Gynecologists
(2005, reaffirmed 2007). Update on carrier screening for cystic fibrosis. ACOG
Committee Opinion No. 325. Obstetrics and Gynecology,
106(6): 1465-1468.
American College of Obstetricians and Gynecologists
and American College of Medical Genetics (2001). Preconception and Prenatal Carrier Screening for Cystic Fibrosis: Clinical and Laboratory Guidelines. Washington, DC: American College of Obstetricians and
Gynecologists.
Stephens K, et al. (2001). Molecular genetic testing:
Cystic fibrosis DNA detection. In DS Jacobs et al., eds., Jacobs and DeMott Laboratory Test Handbook, pp. 701-718.
Hudson, OH: Lexi-Comp.
Other Works Consulted
Boat TF (2004). Cystic fibrosis. In RE Behrman et
al., eds., Nelson Textbook of Pediatrics, 17th ed., pp.
1437-1450. Philadelphia: Saunders.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Genetic Testing for Cystic Fibrosis. NIH Consensus Statement, vol. 15, no. 4 (1997 April
14-16).
American College of Obstetricians and Gynecologists
(2005, reaffirmed 2007). Update on carrier screening for cystic fibrosis. ACOG
Committee Opinion No. 325. Obstetrics and Gynecology,
106(6): 1465-1468.
American College of Obstetricians and Gynecologists
and American College of Medical Genetics (2001). Preconception and Prenatal Carrier Screening for Cystic Fibrosis: Clinical and Laboratory Guidelines. Washington, DC: American College of Obstetricians and
Gynecologists.
Stephens K, et al. (2001). Molecular genetic testing:
Cystic fibrosis DNA detection. In DS Jacobs et al., eds., Jacobs and DeMott Laboratory Test Handbook, pp. 701-718.
Hudson, OH: Lexi-Comp.